Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-κB and AP-1 activation

Megumi Tago, Yoshiko Sonoda, Kenji Tago, Shin Ichi Tominaga, Tadashi Kasahara

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Interleukin-1 (IL-1) is a central regulator of the immune and inflammatory responses by which various inflammatory genes are induced. Although IL-1 signaling is known to involve PI3-kinase, p38 mitogen-activated protein (MAP) kinase and extracellular signal-regulated kinase (ERK), the crosstalk of these kinases on the IL-1-mediated signal transduction is not clear. We used two specific inhibitors, SB203580 which selectively inhibits p38 MAP kinase and LY294002 which inhibits PI3-kinase, respectively, to explore the involvement of these kinases in the IL-1-induced NF-κB activation, using a human glioblastoma cell line, T98G. Two kinase inhibitors decreased IL-1-induced IL-8 mRNA and protein levels markedly. IL-1 caused phosphorylation of p38 MAP kinase with concomitant recruitment of PI3-kinase to IL-1 receptor I (IL-1RI) and its activation. In this context, pretreatment of LY294002, but not SB203580, inhibited IL-1-induced NF-κB activation significantly. While IL-1 induced-AP-1 activation was moderate, both LY294002 and SB203580 suppressed IL-1-induced AP-1 activation. These observations were prominent particularly in the TRAF6 transfection system, in which overexpression of wild type TRAF6 augmented the IL-1 mediated NF-κB and AP-1 activation, while dominant negative TRAF6 construct (ΔTRAF6) suppressed these activation. Namely, LY294002 inhibited TRAF6-mediated IL-1-induced NF-κB and AP-1 activation markedly, while SB203580 inhibited TRAF6-induced AP-1 activation but not NF-κB activation. Above results indicated that both PI3-kinase and p38 MAP kinase are differentially involved in IL-1-induced NF-κB and AP-1 activation.

Original languageEnglish
Pages (from-to)595-604
Number of pages10
JournalInternational Immunopharmacology
Volume1
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Transcription Factor AP-1
p38 Mitogen-Activated Protein Kinases
Phosphatidylinositols
Interleukin-1
Phosphotransferases
TNF Receptor-Associated Factor 6
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Phosphatidylinositol 3-Kinases
Interleukin-1 Receptors
Extracellular Signal-Regulated MAP Kinases
Glioblastoma
Interleukin-8
Transfection
Signal Transduction
Phosphorylation

Keywords

  • IL-1 signaling
  • p38 MAP kinase
  • PI3-kinase
  • TRAF6

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-κB and AP-1 activation. / Tago, Megumi; Sonoda, Yoshiko; Tago, Kenji; Tominaga, Shin Ichi; Kasahara, Tadashi.

In: International Immunopharmacology, Vol. 1, No. 3, 2001, p. 595-604.

Research output: Contribution to journalArticle

@article{fc98fa0a00d845c39dea228c59ec6946,
title = "Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-κB and AP-1 activation",
abstract = "Interleukin-1 (IL-1) is a central regulator of the immune and inflammatory responses by which various inflammatory genes are induced. Although IL-1 signaling is known to involve PI3-kinase, p38 mitogen-activated protein (MAP) kinase and extracellular signal-regulated kinase (ERK), the crosstalk of these kinases on the IL-1-mediated signal transduction is not clear. We used two specific inhibitors, SB203580 which selectively inhibits p38 MAP kinase and LY294002 which inhibits PI3-kinase, respectively, to explore the involvement of these kinases in the IL-1-induced NF-κB activation, using a human glioblastoma cell line, T98G. Two kinase inhibitors decreased IL-1-induced IL-8 mRNA and protein levels markedly. IL-1 caused phosphorylation of p38 MAP kinase with concomitant recruitment of PI3-kinase to IL-1 receptor I (IL-1RI) and its activation. In this context, pretreatment of LY294002, but not SB203580, inhibited IL-1-induced NF-κB activation significantly. While IL-1 induced-AP-1 activation was moderate, both LY294002 and SB203580 suppressed IL-1-induced AP-1 activation. These observations were prominent particularly in the TRAF6 transfection system, in which overexpression of wild type TRAF6 augmented the IL-1 mediated NF-κB and AP-1 activation, while dominant negative TRAF6 construct (ΔTRAF6) suppressed these activation. Namely, LY294002 inhibited TRAF6-mediated IL-1-induced NF-κB and AP-1 activation markedly, while SB203580 inhibited TRAF6-induced AP-1 activation but not NF-κB activation. Above results indicated that both PI3-kinase and p38 MAP kinase are differentially involved in IL-1-induced NF-κB and AP-1 activation.",
keywords = "IL-1 signaling, p38 MAP kinase, PI3-kinase, TRAF6",
author = "Megumi Tago and Yoshiko Sonoda and Kenji Tago and Tominaga, {Shin Ichi} and Tadashi Kasahara",
year = "2001",
doi = "10.1016/S1567-5769(00)00035-7",
language = "English",
volume = "1",
pages = "595--604",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-κB and AP-1 activation

AU - Tago, Megumi

AU - Sonoda, Yoshiko

AU - Tago, Kenji

AU - Tominaga, Shin Ichi

AU - Kasahara, Tadashi

PY - 2001

Y1 - 2001

N2 - Interleukin-1 (IL-1) is a central regulator of the immune and inflammatory responses by which various inflammatory genes are induced. Although IL-1 signaling is known to involve PI3-kinase, p38 mitogen-activated protein (MAP) kinase and extracellular signal-regulated kinase (ERK), the crosstalk of these kinases on the IL-1-mediated signal transduction is not clear. We used two specific inhibitors, SB203580 which selectively inhibits p38 MAP kinase and LY294002 which inhibits PI3-kinase, respectively, to explore the involvement of these kinases in the IL-1-induced NF-κB activation, using a human glioblastoma cell line, T98G. Two kinase inhibitors decreased IL-1-induced IL-8 mRNA and protein levels markedly. IL-1 caused phosphorylation of p38 MAP kinase with concomitant recruitment of PI3-kinase to IL-1 receptor I (IL-1RI) and its activation. In this context, pretreatment of LY294002, but not SB203580, inhibited IL-1-induced NF-κB activation significantly. While IL-1 induced-AP-1 activation was moderate, both LY294002 and SB203580 suppressed IL-1-induced AP-1 activation. These observations were prominent particularly in the TRAF6 transfection system, in which overexpression of wild type TRAF6 augmented the IL-1 mediated NF-κB and AP-1 activation, while dominant negative TRAF6 construct (ΔTRAF6) suppressed these activation. Namely, LY294002 inhibited TRAF6-mediated IL-1-induced NF-κB and AP-1 activation markedly, while SB203580 inhibited TRAF6-induced AP-1 activation but not NF-κB activation. Above results indicated that both PI3-kinase and p38 MAP kinase are differentially involved in IL-1-induced NF-κB and AP-1 activation.

AB - Interleukin-1 (IL-1) is a central regulator of the immune and inflammatory responses by which various inflammatory genes are induced. Although IL-1 signaling is known to involve PI3-kinase, p38 mitogen-activated protein (MAP) kinase and extracellular signal-regulated kinase (ERK), the crosstalk of these kinases on the IL-1-mediated signal transduction is not clear. We used two specific inhibitors, SB203580 which selectively inhibits p38 MAP kinase and LY294002 which inhibits PI3-kinase, respectively, to explore the involvement of these kinases in the IL-1-induced NF-κB activation, using a human glioblastoma cell line, T98G. Two kinase inhibitors decreased IL-1-induced IL-8 mRNA and protein levels markedly. IL-1 caused phosphorylation of p38 MAP kinase with concomitant recruitment of PI3-kinase to IL-1 receptor I (IL-1RI) and its activation. In this context, pretreatment of LY294002, but not SB203580, inhibited IL-1-induced NF-κB activation significantly. While IL-1 induced-AP-1 activation was moderate, both LY294002 and SB203580 suppressed IL-1-induced AP-1 activation. These observations were prominent particularly in the TRAF6 transfection system, in which overexpression of wild type TRAF6 augmented the IL-1 mediated NF-κB and AP-1 activation, while dominant negative TRAF6 construct (ΔTRAF6) suppressed these activation. Namely, LY294002 inhibited TRAF6-mediated IL-1-induced NF-κB and AP-1 activation markedly, while SB203580 inhibited TRAF6-induced AP-1 activation but not NF-κB activation. Above results indicated that both PI3-kinase and p38 MAP kinase are differentially involved in IL-1-induced NF-κB and AP-1 activation.

KW - IL-1 signaling

KW - p38 MAP kinase

KW - PI3-kinase

KW - TRAF6

UR - http://www.scopus.com/inward/record.url?scp=0035090361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035090361&partnerID=8YFLogxK

U2 - 10.1016/S1567-5769(00)00035-7

DO - 10.1016/S1567-5769(00)00035-7

M3 - Article

C2 - 11367542

AN - SCOPUS:0035090361

VL - 1

SP - 595

EP - 604

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 3

ER -